JENNINA MANZANO: Open Payments
NPI 1467112623 · SOUTH PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,095 in 46 payments from 13 companies in 2025. Trend: 2023 $27 · 2024 $533 · 2025 $2,095
Food & beverage: $2,095
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $425 |
| Radius Health, Inc. | 11 | $270 |
| Madrigal Pharmaceuticals | 7 | $212 |
| Insulet Corporation | 6 | $184 |
| Amgen Inc. | 6 | $177 |
| Novo Nordisk Inc | 2 | $130 |
| Astellas Pharma US Inc | 1 | $129 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Ascendis Pharma Endocrinology Inc | 1 | $125 |
| Eisai Inc. | 1 | $122 |
Products named: FREESTYLE LIBRE 3, Tymlos, REZDIFFRA, Omnipod, REPATHA, Vyloy, Yorvipath, Lenvima.
Industry payments across CA — which companies pay providers there.
